We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Trace Metal Concentrations Influence Glucose Regulation in Pregnancy

By LabMedica International staff writers
Posted on 12 Jun 2019
Gestational diabetes is a condition in which a woman without diabetes develops high blood sugar levels during pregnancy. More...
Gestational diabetes generally results in few symptoms; however, it does increase the risk of preeclampsia, depression, and requiring a Caesarean section.

Pregnant women with higher plasma concentrations of copper measured during the first trimester were more likely to have elevated glucose levels in the second trimester, increasing the risk for gestational diabetes (GDM), whereas higher concentrations of the trace metal molybdenum were associated with reduced glucose levels.

Scientists from the Harvard T.H. Chan School of Public Health (Boston, MA, USA) and their colleagues analyzed data from 1,857 healthy, normal-weight women from 12 clinical sites in the USA between July 2009 and January 2013. The team measured concentrations of zinc, selenium, copper and molybdenum in blood plasma samples collected during the first trimester of pregnancy (median, 12 weeks’ gestation). Primary outcome was blood glucose levels during the second trimester after a 1-hour 50 g gestational load test (median, 27 weeks’ gestation).

Among 264 women with an abnormal gestational load test, 58 women were diagnosed with gestational diabetes after an oral glucose tolerance test (OGTT). An additional 76 women with a normal gestational load test also underwent an OGTT, with nine women diagnosed with gestational diabetes. The team found that levels of plasma zinc (median, 806 µg/L) and plasma selenium (median, 123 µg/L) were comparable to measurements among non-pregnant women measured in the National Health and Nutrition Examination Survey (NHANES), whereas levels of copper (median, 1,874 µg/L) were higher versus NHANES-measured levels.

The investigators found that higher concentrations of copper measured during the first trimester were associated with higher glucose levels measured during the second trimester, with each 50% increase in copper concentrations related to a 4.9 mg/dL higher glucose level measured via the gestational load test. In contrast, a 50% increase in molybdenum concentrations was associated with a 1.2 mg/dL lower mean glucose level measured via gestational load test. For every 50% increase in copper concentration, women were 1.53 times more likely to have an abnormal gestational load test and for every 50% increase in molybdenum, women were 14% less likely to have an abnormal gestational load test.

The authors concluded that higher copper and lower molybdenum concentrations could increase the risk of glucose dysregulation during pregnancy, with women at higher risk of GDM potentially affected to a greater extent. Further work is needed to understand the mechanisms involved with early pregnancy essential metal(loid)s in order to inform clinical diagnosis and prevention for glucose intolerance during pregnancy. The study was published on May 16, 2019, in The Journal of Clinical Endocrinology & Metabolism.

Related Links:
Harvard T.H. Chan School of Public Health


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.